Home / Cancer and immune system / Lapatinib
ATC L01EH01 · Antineoplastic Agents
Lapatinib shortage
As of 31 Oct 2026, Lapatinib has a reported shortage in 2 of the 5 countries we track (Italy, Spain), covering 2 products.
Countries2/5
Products2packs or presentations
Short since27 Aug 20262 months ago
Earliest return27 Feb 2027company estimate
No return date1products
Main reasonManufacturing problem
Timeline
ItalySpain
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | TYVERB announced | NOVARTIS EUROPHARM LIMITED | 15 Nov 2026 | not given | Manufacturing problem Problemi produttivi: ridotta disponibilità |
| ES | TYVERB 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 140 comprimidos | Novartis Europharm Limited | 27 Aug 2026 | 27 Feb 2027 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.